Peptides DB
Research-centric peptide and protocol reference hub

Research library

Every indexed study on every peptide in the database, with a machine summary and the numbers that matter pulled out. Filter on the left; the register updates as you go.

1724studies indexed776with human data107registered trials1479carry a numeric findingLibrarian added 0 studies today
Showing 25 studiesSortNewest indexed
C
grade
Epilepsy and premature mortality driven by inhibitory neuron dysfunction in a mouse model of <i>SCN1A</i> gain-of-function neurodevelopmental disorder
VIP (Vasoactive Intestinal Polypeptide) · biorxiv-preprint · 2026 · Animal study · Preclinical
This study demonstrates that SCN1A gain-of-function mutations can lead to severe epilepsy and premature mortality in mice, with potential lifespan extension observed following treatment with GS967.
100% premature mortality in 64/64 mutant mice between postnatal day 12-18.
C
grade
Non-Destructive Analysis of Phenolic and Flavonoid Contents in Medicinal Plant Powders Using Hyperspectral Imaging and Variable Selection.
VIP (Vasoactive Intestinal Polypeptide) · Analytical science advances · 2026 · Observational · n=12High-impact journal
Hyperspectral imaging combined with chemometrics shows promise for non-destructive analysis of phenolic and flavonoid contents in medicinal plants, but further validation is needed.
R² of 0.996 for flavonoid content prediction.
C
grade
UHPLC/Q-TOF-MS-based blood-component profiling and multi-omics analysis reveal potential protective mechanisms of Shenzhuo Formula against diabetic kidney disease.
VIP (Vasoactive Intestinal Polypeptide) · Journal of pharmaceutical and biomedical analysis · 2026 · Animal study · Preclinical
Shenzhuo Formula shows potential in modulating pathways involved in diabetic kidney disease, but human trials are needed to confirm these findings.
Reduced urinary albumin-to-creatinine ratio in db/db mice.
C
grade
Xiongzhi Qufeng Zhitong Granule alleviates nitroglycerin-induced migraine-like nociception and central neuroinflammation by regulating the HMGB1 / TRPV1 / MAPK signaling axis.
VIP (Vasoactive Intestinal Polypeptide) · Journal of ethnopharmacology · 2026 · Animal study · Preclinical
XZQF shows potential in reducing migraine-like symptoms in a rat model, but human studies are needed to confirm its efficacy and safety.
XZQF significantly restored body weight and pain thresholds in rats.
C
grade
ATR-FTIR spectroscopic characterization and interpretable machine learning for time since injury estimation in rat scabs.
VIP (Vasoactive Intestinal Polypeptide) · Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2026 · Observational
ATR-FTIR spectroscopy combined with machine learning shows promise for estimating time since injury in forensic science, but results from rat models may not apply directly to humans.
R²CV = 0.922, RMSECV = 14.456 h for Ridge regression.
A
grade
Impact of oliceridine versus sufentanil on postoperative nausea and vomiting in patients undergoing thyroid surgery: a prospective, double-blind, randomized controlled trial.
VIP (Vasoactive Intestinal Polypeptide) · Annals of medicine · 2026 · RCT · Phase 4 · n=232
Oliceridine may reduce the incidence of postoperative nausea and vomiting compared to sufentanil in patients undergoing thyroid surgery, but further research is needed to confirm these findings in different surgical contexts.
Incidence of PONV within 48 h postoperatively was 12% in the oliceridine group vs 28% in the sufentanil group, OR = 0.35, 95% CI: 0.17-0.72, p = 0.006.
B
grade
Quality of patient-reported outcome reporting and related trial characteristics in randomized controlled trials of cancer pain: A systematic review based on the CONSORT-PRO extension.
VIP (Vasoactive Intestinal Polypeptide) · Asia-Pacific journal of oncology nursing · 2026 · Observational · n=3841
The reporting completeness of patient-reported outcomes in cancer pain trials is moderate at 65.65%, indicating a need for improved adherence to reporting guidelines.
Overall mean CONSORT-PRO reporting completeness was 65.65%.
B
grade
Vasoactive-Inotropic Score and in-hospital mortality in preterm infants &lt; 34 weeks' gestation with early pulmonary hypertension in the setting of respiratory distress and sepsis.
VIP (Vasoactive Intestinal Polypeptide) · The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2026 · Observational · n=238
Higher Vasoactive-Inotropic Scores in the first 24 hours after pulmonary hypertension diagnosis are associated with increased in-hospital mortality in preterm infants, indicating a need for careful monitoring and risk assessment.
Each 10-unit increase in VISmax-24h was associated with OR 1.42 (95% CI 1.21-1.66; p<0.001).
C
grade
Sensory stimulation triggers different spike responses in serotonin and dopamine neurons in the dorsal midbrain tegmentum
VIP (Vasoactive Intestinal Polypeptide) · biorxiv-preprint · 2026 · Observational
Over 57% of neurons in the dorsal midbrain tegmentum respond to foot shock and mechanical stimuli, while less than 15% respond to light or acoustic stimuli, indicating distinct activation patterns in serotonin and dopamine neurons.
>57% of DRN/vlPAG neurons responded to foot shock and mechanical stimulation.
C
grade
An integrated single-cell transcriptomic pipeline identifies ZNF740/BRD3 and Cathepsin S as novel therapeutic targets in chronic active rim smoldering multiple sclerosis
VIP (Vasoactive Intestinal Polypeptide) · biorxiv-preprint · 2026 · Observational · Phase 1
This study identifies ZNF740, Cathepsin S, and DNMT1 as potential new targets in smoldering MS, but further research is needed to establish their clinical relevance.
394 upregulated candidates (log₂FC ≥ 0.5, FDR < 0.1) from 1,065 total CA-RIM DEGs.
Showing 25 of 25